• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Melanoma & Skin Cancer - Articles and news items

SMC u turn lifeline

SMC ‘U-turn’ offers lifeline to Scottish skin cancer patients

Industry news / 8 August 2016 / Bristol-Myers Squibb

The SMC initially refused access to nivolumab for Scottish patients, having taken a different view to the National Institute for Health and Care Excellence (NICE), which approved it to treat patients in England and Wales. However, following a review of additional evidence, the SMC decision has been reversed, bringing access in Scotland on par with the rest of the UK…

melanoma

SCIB1 continues to deliver encouraging survival data in melanoma

Industry news / 6 July 2016 / Victoria White, Digital Content Producer

Scancell has provided an update from the SCIB1 Phase I/II clinical trial in malignant melanoma, the lead programme from the Company’s ImmunoBody platform…

ECHO-301

First patient treated in the Phase III ECHO-301 study

Industry news / 23 June 2016 / Victoria White, Digital Content Producer

ECHO-301 will evaluate Incyte’s epacadostat with Merck’s pembrolizumab as first-line treatment for patients with advanced or metastatic melanoma…

nivolumab

NICE recommends nivolumab + ipilimumab for advanced melanoma

Industry news / 17 June 2016 / Victoria White, Digital Content Producer

The NHS will receive a discount on the combination treatment agreed between Bristol-Myers Squibb and the Department of Health…

tafinlar

Novartis presents new data for Tafinlar + Mekinist at ASCO

Industry news / 7 June 2016 / Victoria White, Digital Content Producer

Novartis has announced new data for the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) in non-small cell lung cancer (NSCLC) and melanoma…

IMCgp100

Positive Phase I data for IMCgp100 in metastatic melanoma

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Immunocore has announced positive data from the first in human, Phase I clinical trial of its lead ImmTAC, IMCgp100…

immunotherapy

Study describes extraordinarily potent mRNA cancer immunotherapy

Industry news / 2 June 2016 / Victoria White, Digital Content Producer

BioNTech has announced the publication of a study that describes the first example of a clinically relevant and systemic mRNA cancer immunotherapy…

advanced melanoma

EC approves Opdivo + Yervoy regimen for advanced melanoma

Industry news / 11 May 2016 / Victoria White, Digital Content Producer

The approval of Opdivo + Yervoy represents the first and only approved combination of two Immuno-Oncology agents in the European Union (EU)…

trametinib

NICE recommends trametinib plus dabrafenib in melanoma

Industry news / 3 May 2016 / Victoria White, Digital Content Producer

NICE has published final draft guidance recommending trametinib in combination with dabrafenib to treat some patients with melanoma…

Proteomic Mass Spectrometry

Proteomic mass spectrometry imaging for detecting malignant melanoma

Blog, Z Homepage promo / 26 April 2016 / Victoria White, Digital Content Producer

In an exclusive interview, Erin Seeley of Protea Biosciences discusses Proteomic Mass Spectrometry Imaging and Protea’s recently announced license agreement with Yale…

Opdivo and Yervoy

Opdivo and Yervoy combination demonstrates superior efficacy in melanoma study

Industry news / 18 April 2016 / Victoria White, Digital Content Producer

A Opdivo and Yervoy combination regimen demonstrated a two-year OS rate of 69% compared to 53% for Yervoy alone in BRAF wild-type advanced melanoma…

IMCgp100

First patient recruited in IMCgp100 uveal melanoma trial

Industry news / 30 March 2016 / Victoria White

The trial of IMCgp100 will include three Phase I escalation cohorts to determine the optimal dose for the Phase II study, which is expected to start in 2016…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +